4.7 Article

Flavonoids increase melanin production and reduce proliferation, migration and invasion of melanoma cells by blocking endolysosomal/melanosomal TPC2

Journal

SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-021-88196-6

Keywords

-

Funding

  1. German Research Foundation [SFB/TRR152 TP04]
  2. German Research Foundation (DFG) [GR-4315/2-1]
  3. German Research Foundation (DAAD) [57453751]
  4. German Research Foundation (TRF Project) [4.E.CU/59/E.1]
  5. Chulalongkorn University Natural Product Biotechnology Research Unit [GRU 6205633003-1]
  6. NIH [GM-125619]

Ask authors/readers for more resources

Studies have shown an inverse correlation between TPC2 activity in endolysosomes and melanosomes and melanin production, melanoma proliferation, migration, and invasion. Inhibiting TPC2 can increase melanin synthesis in melanosomes by interfering with tyrosinase activity and decrease melanoma progression driven by MITF through GSK3 beta-mediated MITF degradation.
Two-pore channel 2 (TPC2) resides in endolysosomal membranes but also in lysosome-related organelles such as the melanin producing melanosomes. Gain-of-function polymorphisms in hTPC2 are associated with decreased melanin production and blond hair color. Vice versa genetic ablation of TPC2 increases melanin production. We show here an inverse correlation between melanin production and melanoma proliferation, migration, and invasion due to the dual activity of TPC2 in endolysosomes and melanosomes. Our results are supported by both genetic ablation and pharmacological inhibition of TPC2. Mechanistically, our data show that loss/block of TPC2 results in reduced protein levels of MITF, a major regulator of melanoma progression, but an increased activity of the melanin-generating enzyme tyrosinase. TPC2 inhibition thus provides a twofold benefit in melanoma prevention and treatment by increasing, through interference with tyrosinase activity, the synthesis of UV blocking melanin in melanosomes and by decreasing MITF-driven melanoma progression by increased GSK3 beta-mediated MITF degradation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available